The legal status of patient-delivered partner therapy for sexually transmitted infections in the United States: a national survey of state medical and pharmacy boards.
OBJECTIVE
The objective of this study was to define the legal status of patient-delivered partner therapy (PDPT) in the United States.


METHODS
A survey of directors of state boards of pharmacy and medicine in the 50 United States and the District of Columbia was performed.


RESULTS
Completed surveys were returned by 37 (72%) pharmacy boards and 37 (72%) medical boards representing 47 states. PDPT was clearly defined as legal in four states. PDPT was regarded as illegal by 16 (43%) medical boards and 19 (51%) pharmacy boards and as of uncertain legality by 16 (43%) medical boards and 14 (38%) pharmacy boards. Most boards (88%) that regarded PDPT as illegal or of uncertain legality indicated that the issue had never been addressed.


CONCLUSIONS
The legal status of PDPT is uncertain in much of the U.S., and the practice is often considered illegal. New laws or legal rulings will be needed if PDPT is to be widely promoted.
Golden
Matthew R
MR
Division of Infectious Diseases and the Center for AIDS and STD, University of Washington, Seattle, Washington 98104, USA. golden@u.washington.edu
Anukam
Uzoeshi
U
Williams
Donald H
DH
Handsfield
H Hunter
HH
D000890:Anti-Infective Agents / Q000008:administration & dosage*; D004363:Drug Utilization / Q000331:legislation & jurisprudence* / Q000592:standards; D006306:Health Surveys; D006801:Humans; D007883:Legislation, Medical; D007885:Legislation, Pharmacy; D010349:Patient Compliance; D010818:Practice Patterns, Physicians' / Q000331:legislation & jurisprudence* / Q000592:standards; D012747:Sexual Partners; D012749:Sexually Transmitted Diseases / Q000517:prevention & control*; D013044:Specialty Boards; D014481:United States / Q000453:epidemiology
D000890:Anti-Infective Agents